Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Ablation soon after first implantable cardioverter defibrillator shock for ventricular tachycardia ...
Ventricular tachycardia (VT) ablation should be considered after the first implantable cardioverter defibrillator (ICD) shock in patients with ischemic or nonischemic cardiomyopathy, the PARTITA trial ...
Please provide your email address to receive an email when new articles are posted on . A single burst of antitachycardia pacing (ATP) reduced risk for shocks in patients with an implantable ...
WASHINGTON -- Researchers made a strong case that earlier was better when it comes to catheter ablation of ventricular tachycardias (VTs) in people with implantable cardiac defibrillators (ICDs).
(HealthDay News) — For patients with cardiomyopathy, use of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) is associated with significantly lower incidence of ...
In patients younger than 19 with implantable cardioverter defibrillators, a lower body weight, indicating younger age, is ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. (“AtaCor”) announced today that it will present initial findings from its first-in-human extravascular implantable cardioverter ...
NATICK, Mass. and SAN FRANCISCO, Boston Scientific Corporation today announced results from an analysis of its ALTITUDE ® Clinical Science program, which demonstrated that defibrillator therapy saves ...
Evidence indicates that at least 50% of patients with an Implantable Cardioverter Defebrilatior (ICD) are anxious at the time of implantation. This is excalated when they receive a shock from their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback